daunorubicin has been researched along with Chromosome-Defective Micronuclei in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertoli, A; Federico, G; Fiore, L; Paganucci, L; Pistelli, L; Scarpato, R | 1 |
| Ferguson, LR; Hill, CL; Morecombe, P | 1 |
| Ciechanowska, U; Konopacka, M; Rytwiński, K; Sońta-Jakimczyk, D | 1 |
3 other study(ies) available for daunorubicin and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
Licoflavone C attenuates the genotoxicity of cancer drugs in human peripheral lymphocytes.
Topics: Antimutagenic Agents; Cytoprotection; Daunorubicin; Flavones; Genista; Humans; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mitomycin; Molecular Structure; Plant Extracts | 2008 |
Induction of resistance to 6-thioguanine and cytarabine by a range of anticancer drugs in Chinese hamster AA8 cells.
Topics: Amsacrine; Animals; Antineoplastic Agents; Bleomycin; Carmustine; CHO Cells; Clone Cells; Cricetinae; Cytarabine; Daunorubicin; DNA Damage; Drug Resistance; Ethyl Methanesulfonate; Micronuclei, Chromosome-Defective; Stem Cells; Thioguanine; Time Factors; Topoisomerase I Inhibitors; Tumor Stem Cell Assay | 1992 |
[Anemia and recurrences in acute lymphoblastic leukemia in children after the treatment and the frequency of the erythroblasts with micronuclei].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; beta-Thalassemia; Bone Marrow; Child; Child, Preschool; Daunorubicin; Erythrocytes; Hematopoietic Stem Cells; Humans; Infant; Micronuclei, Chromosome-Defective; Micronucleus Tests; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 1992 |